Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (SHA:603896)
China · Delayed Price · Currency is CNY 14.85
-0.10 (-0.67%)
Aug 4, 2026, 3:00 PM CST
SHA:603896 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 625.3 | 640.18 | 705.11 | 784.35 | 829.07 | 767.14 |
Revenue Growth | -5.27% | -9.21% | -10.10% | -5.39% | 8.07% | 20.61% |
Gross Profit Gross Profit Growth | 486.26 | 503.63 | 565.1 | 648.82 | 699.86 | 640.76 |
Operating Income Operating Income Growth | 60.14 | 86.27 | 121.36 | 201.09 | 238.45 | 184.3 |
Net Income Net Income Growth | -11.56 | 18.17 | 174.44 | 254.48 | 277.78 | 200.83 |
Earnings Per Share EPS Growth | -0.06 | 0.09 | 0.88 | 1.30 | 1.43 | 1.05 |
EPS Growth | - | -89.77% | -32.31% | -9.09% | 36.19% | 27.57% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Manufacturing Manufacturing Growth | 606.3 |
Other Other Growth | 22.3 |
Total Total Growth | 628.6 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,058 | 1,135 | 1,199 | 1,504 | 1,555 | 807.98 |
Total Debt Total Debt Growth | 564.45 | 614.98 | 588.11 | 748.4 | 706.41 | 106.56 |
Net Cash (Debt) Net Cash Growth | 493.62 | 519.57 | 610.61 | 755.56 | 848.31 | 701.42 |
Net Cash Growth | -17.22% | -14.91% | -19.18% | -10.93% | 20.94% | 32.06% |
Net Cash Per Share Net Cash Per Share Growth | 2.47 | 2.57 | 3.08 | 3.86 | 4.37 | 3.67 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 188.37 | 228.07 | 214.97 | 315.06 | 341.28 | 296.7 |
Capital Expenditures CapEx Growth | -254.24 | -273.22 | -507.07 | -414.54 | -182.6 | -161.63 |
Free Cash Flow Free Cash Flow Growth | -65.87 | -45.15 | -292.1 | -99.48 | 158.68 | 135.07 |
Free Cash Flow Growth | - | - | - | - | 17.48% | -29.42% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 77.76% | 78.67% | 80.14% | 82.72% | 84.41% | 83.53% |
Operating Margin | 9.62% | 13.48% | 17.21% | 25.64% | 28.76% | 24.02% |
Pretax Margin | 11.79% | 15.95% | 24.75% | 32.50% | 33.53% | 26.21% |
Profit Margin | -1.85% | 2.84% | 24.74% | 32.45% | 33.51% | 26.18% |
FCF Margin | -10.53% | -7.05% | -41.43% | -12.68% | 19.14% | 17.61% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.270 | - | 0.270 | 0.390 | 0.440 | 0.311 |
Dividend Per Share Growth | -30.77% | - | -30.77% | -11.36% | 41.25% | 29.79% |
Dividend Yield | 1.82% | - | 1.29% | 1.24% | 1.15% | 0.73% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 211.40 | 24.11 | 25.12 | 28.16 | 43.99 |
Forward PE | - | 22.02 | 13.91 | 20.94 | 23.38 | 39.93 |
P/FCF Ratio | - | - | - | - | 49.29 | 65.41 |
PS Ratio | 4.71 | 6.00 | 5.96 | 8.15 | 9.43 | 11.52 |